-
First cases of treatment-resistant ringworm found in patients in US | US News
admin
Two cases of highly contagious, drug-resistant ringworm infection have been detected in the US. The cases were reported to the Centers for Disease Control and Prevention (CDC) in February and shared in a report published on Thursday. The patients, from New York City, had their first symptoms in 2021 and 2022. One of the patients…
-
New long COVID drug may significantly reduce fatigue in patients | UK News
admin
An experimental drug could significantly reduce fatigue in people with long COVID, a new study suggests. Scientists who carried out the small-scale clinical trial believe the drug, called AXA1125, may increase energy production in cells and reduce inflammation for people fighting the virus and its aftereffects. They are calling for larger studies to confirm the…
-
Smartwatches and fitness trackers could trigger heart attacks in vulnerable patients | Science & Tech News
admin
Smartwatches and wearable fitness devices could trigger a heart attack in vulnerable patients and potentially be deadly, a new study has warned. The study carried out by researchers from the University of Utah and published in the Heart Rhythm journal, found that Samsung Galaxy Watch4, Fitbit smart scales, and Moodmetric smart rings, among many others…
-
Unvaccinated COVID patients ‘at greater risk of death’ for at least 18 months after infection | Science & Tech News
admin
Unvaccinated COVID patients retain a greater risk of death and cardiovascular disease for at least 18 months after infection, new research suggests. The findings come following a study of more than 160,000 people during the first year of the coronavirus pandemic – before any jabs were available. Those who caught the disease between March and…
-
What is Alzheimer’s disease, how common is it – and will new drug lecanemab help patients in the UK? | UK News
admin
A new drug is making headlines around the world for being the first ever to slow the progression of Alzheimer’s disease. After an 18-month trial of 1,800 patients, lecanemab slowed patients’ mental decline by 27%. Although scientists are hailing a “new era” in treatment, strains on the NHS and the scale and complexity of the…
-
‘Pioneering’ new smart glasses to be trialled by nurses to help them spend more time with patients | Science & Tech News
admin
New virtual reality-style goggles are to be trialled by nurses on home visits, in an effort to maximise the amount of time spent with patients, the NHS has said. Smart glasses will, in real time, transcribe appointments straight to electronic records, so the time spent doing administration tasks is reduced. In turn, more time will…